FDA applicant
Bigfoot Biomedical, Inc.
FDA records 2 decisions for Bigfoot Biomedical, Inc. (Milpitas, CA) from 2021 to 2023: 2 510(k) clearances. All are in product code QLG (Integrated Continuous Glucose Monitoring…). Its devices cite 2 predicates, 1 of them its own earlier devices. 1 recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Bigfoot Biomedical, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2023
2026 so far, outlined.
Recalls per year
1in 2025
Class I Class II/III not classified
Planning a device like Bigfoot Biomedical, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report